Drag to reposition your photo

Violet

Female. Lives in India.

Friends

Admin

Violet

Link

Violet

January 22, 2026 5:14 am

Global Pharmacogenomics (PGX) Market to Reach USD 11.17 Billion by 2033, Advancing at a 6.6% CAGR Driven by Precision Medicine Adoption The global pharmacogenomics (PGX) market size was valued at USD... View MoreGlobal Pharmacogenomics (PGX) Market to Reach USD 11.17 Billion by 2033, Advancing at a 6.6% CAGR Driven by Precision Medicine Adoption The global pharmacogenomics (PGX) market size was valued at USD 6.13 billion in 2024 and is projected to grow from USD 6.69 billion in 2025 to USD 11.17 billion by 2033, exhibiting a CAGR of 6.6% during the forecast period (2025-2033). Market Scope and Research Methodology This report provides an in-depth analysis of the Pharmacogenomics (PGX) Market at global, regional, and country levels. It examines market size, regional performance, and competitive strategies of leading companies, supported by a SWOT analysis. The study uses a robust methodology combining primary and secondary research with validated forecasting techniques to deliver accurate and reliable market insights. The main goal of this report is to offer actionable insights into Pharmacogenomics (PGX) Market trends, growth drivers, and key factors affecting industry performance. It covers market structure, segmentation, and projected market value, while identifying growth opportunities, challenges, and trends shaped by technology, regulations, cost efficiency, and changing consumer demand. Download Sample Report PDF https://straitsresearch.com/report/pharmacogenomics-market/request-sample Regional Insights The report provides detailed analysis across major regions, including North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Each region is evaluated for Pharmacogenomics (PGX) Market size, growth trends, trade patterns, and overall industry maturity. This segmentation helps identify competitive strengths and untapped growth potential in each region. Market Segmentation By Type Products Genotyping Kits Sequencing Instruments PCR Reagents and Consumables Sample Preparation Kits Others Services Genetic Testing Services Pharmacogenomic Consulting Others Software Bioinformatics Software Clinical Decision Support System Laboratory Information Management System EHR Integration Software Others By Technology Next-Generation Sequencing Polymerase Chain Reaction Mass Spectrometry Microarray Others By Application Cardiovascular disease Infectious diseases Oncology Neurological diseases Pain Management and Trauma Others By End-User Hospitals Clinical Laboratories Pharmaceutical Companies Academic Research Institutions Others Key Market Players QIAGEN Illumina, Inc. Agilent Technologies, Inc. Foundation Medicine, Inc. Thermo Fisher Scientific Inc. Admera Health Myriad Genetics, Inc. Beckman Coulter, Inc. OneOme Genomind Coriell Life Sciences PGxAI Tempus DEEP GENOMICS Helix, Inc. Oxford Nanopore Technologies plc. Download Sample Report PDF https://straitsresearch.com/report/pharmacogenomics-market/request-sample Key Questions Answered in the Report What is the market overview of the Pharmacogenomics (PGX) Market? What was the market size in 2024? What is the projected CAGR during the forecast period? Which factors are driving market growth? How is the market segmented? What strategies are adopted by leading companies? Which trends and applications are shaping industry development? Who are the top participants in the market? What are the key capabilities and product offerings of leading companies? About Us Straits Research has over 10 years of experience providing data-driven insights to more than 2,025 organizations worldwide, from startups to global enterprises. Our syndicated research reports cover high-impact industries such as chemicals, food and beverages, healthcare, automotive, technology, aerospace, and defense. We also offer customized research solutions to support strategic decision-making and business growth.

View Less

Pharmacogenomics (PGX) Market Size, Top Share, Demand | Industry Report, 2033

straitsresearch.com

Request Free Sample : The global pharmacogenomics (PGX) market size is projected to grow from USD 6.69 billion in 2025 to USD 11.17 billion by 2033, exhibiting a CAGR of 6.6%.

Be the first person to like this.

Recent Photos

View More Photos